Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences (FBRX) Other Accumulated Expenses (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Other Accumulated Expenses for 5 consecutive years, with $81000.0 as the latest value for Q3 2020.

  • Quarterly Other Accumulated Expenses fell 95.43% to $81000.0 in Q3 2020 from the year-ago period, while the trailing twelve-month figure was $81000.0 through Sep 2020, down 95.43% year-over-year, with the annual reading at $2000.0 for FY2019, 99.88% down from the prior year.
  • Other Accumulated Expenses for Q3 2020 was $81000.0 at Forte Biosciences, down from $133000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $2.2 million in Q2 2019, with the low at $2000.0 in Q4 2019.
  • Average Other Accumulated Expenses over 5 years is $970812.5, with a median of $823000.0 recorded in 2017.
  • The sharpest move saw Other Accumulated Expenses skyrocketed 229.73% in 2018, then tumbled 99.88% in 2019.
  • Over 5 years, Other Accumulated Expenses stood at $312000.0 in 2016, then soared by 199.04% to $933000.0 in 2017, then surged by 74.6% to $1.6 million in 2018, then crashed by 99.88% to $2000.0 in 2019, then surged by 3950.0% to $81000.0 in 2020.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $81000.0, $133000.0, and $344000.0 for Q3 2020, Q2 2020, and Q1 2020 respectively.